Sign in
4

Changes in Ownership

Summit Therapeutics Inc. Filed Acc 0001963544-25-000004

Director bought 533,617 shares at $18.74 ($9,999,983)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Xia Yu Director 2025-10-21 Purchase +533,617 $18.74 $9,999,983 32,057,147 I: show line 1 in the form
Open-market purchases · 533,617 sh · avg $18.74 · $9,999,983
Loading xslF345X05/wk-form4_1761267986.xml…